Showing results (61-70 of 171) with videos related to
Sort By:
Pageof 18
BMC Cancer|September 24, 2022
Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease - a randomized, open-label, multicenter phase II trialFarastuk Bozorgmehr, Petros Christopoulos, Inn Chung, et al.Cold Spring Harbor Molecular Case Studies|October 7, 2022
Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case reportChristiane Wiedemann, Daniel Kazdal, Jelena Cvetkovic, et al.Journal of Surgical Oncology|December 18, 2025
Impact of Combined Additional Resections on the Surgical Outcomes of Robot-Assisted Resection of Thymic Epithelial TumorsBenedikt Niedermaier, Nabil Khan, Florian Eichhorn, et al.Cancers|June 10, 2022
Early Development of Ubiquitous Acanthocytosis and Extravascular Hemolysis in Lung Cancer Patients Receiving AlectinibJulia Kunz, Christiane Wiedemann, Heidrun Grosch, et al.Lung Cancer (Amsterdam, Netherlands)|October 30, 2020
Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)Martin Faehling, Christian Schumann, Petros Christopoulos, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|March 15, 2024
The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancerSarah Richtmann, Sebastian Marwitz, Thomas Muley, et al.Clinical Therapeutics|November 2, 2025
Real-World Characteristics, Treatment Patterns, and Outcomes in Advanced HER2 (ERBB2)-Mutant Non-Small Cell Lung Cancer: A Retrospective Study of Single Centers in France and GermanyPetros Christopoulos, Christin Assmann, Lirong Zhang, et al.Journal for Immunotherapy of Cancer|September 20, 2023
Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse eventsKarolina Gente, Leonore Diekmann, Lea Daniello, et al.Frontiers in Oncology|July 26, 2021
Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung CarcinomaDavid Fisch, Farastuk Bozorgmehr, Daniel Kazdal, et al.Clinical Medicine Insights. Oncology|September 5, 2020
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IVWolfgang M Brueckl, Martin Reck, Achim Rittmeyer, et al.Pageof 18